spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  zolpidem 

 HSMN NewsFeed - 11 Mar 2019
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Jun 2016
Pernix Therapeutics Announces Positive Phase IV Results of Silenor(R) vs. Zolpidem Head-to-Head Arousability Study
Biopharmaceuticals
 HSMN NewsFeed - 30 Apr 2013
ECR Pharmaceuticals Announces Re-launch of Zolpimist(R) and DexPak(R), Divestiture of Hylase(R) and Orbivan(R) Brands, and Dr. Cameron Durrant Named President and CEO
Biopharmaceuticals Personnel Product Launch
 HSMN NewsFeed - 10 Jan 2013
FDA Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Sep 2012
Ventrus Biosciences Appoints JP Benya Vice President, Commercial Operations and Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2012
Transcept Pharmaceuticals Announces National Product Launch of Intermezzo(R) by Purdue Pharma L.P.
Biopharmaceuticals
 HSMN NewsFeed - 4 Feb 2011
Zolpimist(TM) Oral Spray Launched in United States
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 Feb 2011
ECR Pharmaceuticals Launches Zolpimist Oral Spray
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 22 Feb 2010
Transcept Pharmaceuticals Provides Update on Intermezzo(R) Regulatory Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Oct 2009
Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Mar 2009
Orexo's Edluar (Sublinox) Receives FDA Approval for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Feb 2009
Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Jan 2009
Novacea Stockholders Approve Merger With Transcept
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Oct 2008
Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP
Biopharmaceuticals
 HSMN NewsFeed - 1 Oct 2008
Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 Sep 2008
Ranbaxy Statement on FDA Letters
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Jun 2008
Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2008
Meda and Orexo in a Potential Billion SEK Deal
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 23 Jan 2008
NovaDel's New Drug Application for ZolpiMist(TM) Oral Spray to Treat Insomnia Accepted for Filing by the U.S. Food and Drug Administration
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 4 Jan 2008
Ambien CR(R) (zolpidem tartrate extended-release) tablets CIV Improved Chronic Insomnia in Patients with Co-Morbid Generalized Anxiety Disorder
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2007
New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
Biopharmaceuticals
 HSMN NewsFeed - 1 Oct 2007
Orexo Shows Positive Results in Completed Comparative Phase III Profile Study of the Sublinox(TM) Sleep Aid Involving Insomnia Patients
Biopharmaceuticals
 HSMN NewsFeed - 25 Jul 2007
Jan H. Egberts, M.D. Resigns as President and CEO of NovaDel Pharma
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2007
TransOral Pharmaceuticals, Inc. Changes Name to Transcept Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 26 Apr 2007
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Apr 2007
Dr. Reddy's Announces the Launch of Zolpidem Tartrate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Apr 2007
Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg
Biopharmaceuticals Generics
 HSMN NewsFeed - 23 Apr 2007
Prasco Enters into Agreement with sanofi-aventis to Market the Authorized Generic Versions of Ambien(R) (Zolpidem Tartrate) CIV
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 23 Apr 2007
Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Apr 2007
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Apr 2007
Barr Confirms Patent Challenge of Ambien CR(R)
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 23 Mar 2007
NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
Biopharmaceuticals
 HSMN NewsFeed - 6 Mar 2007
TransOral Pharmaceuticals Raises $40 Million in Series D Financing. Proceeds Will Be Used to Complete Intermezzo(TM) Phase 3 Clinical Trials and File NDA
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Feb 2007
NovaDel Pharma Announces the Completion of Its Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2007
Successful Proof-of-Concept With Actelion's Orexin Receptor Antagonist in Patients Suffering From Primary Insomnia -- First Demonstration of Key Role of Orexin System in Humans Suffering From Sleep Disorders
Biopharmaceuticals
 HSMN NewsFeed - 3 Nov 2006
NovaDel Pharma Receives FDA Approval of NitroMist(TM)
Biopharmaceuticals Drug Delivery FDA Cardiology
 HSMN NewsFeed - 12 Jul 2006
New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate extended- release) Tablets C(IV) for up to 24 Weeks
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 17

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 17 additional stories matching:
zolpidem
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.